Changes in generic pill color and shape disrupt use

Researchers find that changes in pill appearance associated with non-adherence to essential cardiovascular drugs

2014-07-15

(Press-News.org) Boston, MA—Generic versions of the same prescription drug are clinically interchangeable but often look different depending on the manufacturer. The FDA does not require consistent pill appearance among interchangeable generic drugs, and the shape and color of patients' pills may vary based on the particular supply at the patient's pharmacy. Studying a national cohort of patients who recently suffered a heart attack, researchers from Brigham and Women's Hospital (BWH) have found that variation in appearance of generic drugs is associated with a greater risk of patients stopping their essential post-heart attack drugs. These findings are published on July 14, 2014 in the Annals of Internal Medicine.

"After patients have a first heart attack, guidelines mandate treatment with an array of long-term medications and stopping these medications may ultimately increase morbidity and mortality," explains Aaron S. Kesselheim, MD, JD, MPH, assistant professor of medicine in the Division of Pharmacoepidemiology and Pharmacoeconomics at BWH and senior investigator of this study. "Medications are essential to the treatment of cardiovascular disease and our study found that pill appearance plays an important role in ensuring patients are taking the generic medications that they need."

In a large national insurance database, the researchers collected records of over 10,000 patients discharged between 2006 and 2011 after hospitalizations for heart attacks who initiated treatment with generic beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin-II-receptor blockers, or cholesterol-lowering statins. They then looked for breaks in medication refilling (non-adherence) and they determined whether the pill appearance had changed in the prior two prescriptions. They found that the odds that a patient would discontinue use or not refill their medication increased by 34 percent after a change in color and 66 percent after a change in pill shape.

"The association between changes in pill appearance and non-adherence to essential cardiovascular medications has important implications for public health," explained Kesselheim. "This study suggests the need for physicians and pharmacists to proactively warn patients about the potential for these changes, and reassure them that generic drugs are clinically interchangeable no matter how they look, especially in light of the prevalent use of generic drugs and public health importance of promoting patient adherence to essential medications."

INFORMATION: This research was supported by the Agency for Healthcare Research and Quality and the Harvard Program in Therapeutic Science. Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs nearly 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, more than 1,000 physician-investigators and renowned biomedical scientists and faculty supported by nearly $650 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals. BWH continually pushes the boundaries of medicine, including building on its legacy in transplantation by performing a partial face transplant in 2009 and the nation's first full face transplant in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom.

ELSE PRESS RELEASES FROM THIS DATE:

Bonuses for doctors do little to improve cancer screening in Ontario

2014-07-15

TORONTO, July 14, 2014 – Ontario spent nearly $110 million dollars between 2006 and 2010 on bonuses to motivate family doctors to screen more of their patients for cancer but these bonuses were associated with little or no improvement in actual cancer screening rates, according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES). The study, published today in Annals of Family Medicine, tracked screening rates for cervical, breast and colorectal cancer in Ontario each year between 2000 and 2010. Researchers found no significant ...

July/August 2014 Annals of Family Medicine tip sheet

2014-07-15

High Prevalence of Unsafe All-Terrain Vehicle Ridership Among Adolescents in Iowa More youth are killed every year in the United States in all-terrain vehicle crashes than on bicycles, and since 2001, one-fifth of all ATV fatalities have involved victims aged 15 years or younger. To better understand ATV riding practices among adolescents, researchers surveyed 4,684 youths aged 11 to 16 years at 30 schools across Iowa and found the vast majority reported having ridden an ATV, and most practiced unsafe riding behaviors and had experienced at least one crash. Specifically, ...

New combination drug controls tumor growth and metastasis in mice

2014-07-15

SACRAMENTO, Calif. — Researchers at UC Davis, University of Massachusetts and Harvard Medical School have created a combination drug that controls both tumor growth and metastasis. By combining a COX-2 inhibitor, similar to Celebrex, and an epoxide hydrolase (sEH) inhibitor, the drug controls angiogenesis (blood vessel formation), limiting a tumor's ability to grow and spread. The study appears today in the journal Proceedings of the National Academy of Sciences. "We've been studying the effects of COX and sEH inhibitors, both by themselves and in combination, for several ...

Home blood pressure-monitoring kits save insurance companies money

2014-07-14

Home blood pressure-monitoring kits can save insurance companies money by improving healthcare quality and reducing healthcare costs, according to new research in the American Heart Association's journal Hypertension. In the United States, more than 76 million adults have diagnosed high blood pressure, and many more are undiagnosed. Since high blood pressure typically has no symptoms, periodic testing is critical especially for people with the factors that put them at risk for the condition. Home monitoring kits effectively test blood pressure at regular intervals over ...

Hispanic Americans need culturally tailored heart care

2014-07-14

A first-time comprehensive overview of cardiovascular disease among Hispanics in the U.S. outlines the burden of heart disease and stroke as well as emphasizes the importance of culturally appropriate healthcare for this population. The American Heart Association scientific statement is published in the Association's journal Circulation. Hispanics represent the fastest-growing racial or ethnic population in the United States and are expected to constitute 30 percent of the total U.S. population by the year 2050. Yet, there is no comprehensive document about the cultural ...

Prostate cancer is focus of 2 studies, commentary

2014-07-14

Bottom Line: Management of low-risk prostate cancer (which is unlikely to cause symptoms or affect survival if left untreated) varies widely among urologists and radiation oncologists, with patients whose diagnosis is made by a urologist that treats non-low-risk prostate cancer more likely to receive treatment vs. observation. Author: Karen E. Hoffman, M.D., M.H.Sc., of the University of Texas MD Anderson Cancer Center, Houston, and colleagues. Background: Most men in the United States with low-risk prostate cancer usually receive treatment with prostatectomy or radiotherapy ...

Study examines dietary fatty acid intake, risk for Lou Gehrig disease

2014-07-14

Bottom Line: Eating foods high in ω-3 polyunsaturated fatty acids (PUFAs) from vegetable and marine sources may help reduce the risk for amyotrophic lateral sclerosis (ALS), the fatal neurodegenerative disease commonly referred to as Lou Gehrig's disease. Author: Kathryn C. Fitzgerald, M.Sc., of the Harvard School of Public Health, Boston, and colleagues. Background: PUFAs can help modulate inflammation and oxidative stress, mechanisms that have been implicated in the cause of ALS and other neurodegenerative diseases. But data regarding PUFA intake and ALS risk ...

Study finds diagnosing physicians influence therapy decisions for prostate cancer patients

2014-07-14

New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result. The findings, published in JAMA Internal Medicine, sought to examine why active surveillance, a management program for low-risk disease, which includes repeat PSAs, prostate exams and biopsies, is underused in this patient population. According to the American Cancer Society, 233,000 new ...

The power of making amends

2014-07-14

CORAL GABLES, Fla. -- It's well known that when a person takes steps to make amends for a wrongdoing, the victim is more inclined to forgive and forget. However, exactly why that happens is less obvious and poorly understood. In a recent study, scientists made substantial progress in explaining the psychological processes that make forgiveness happen. Their findings show that peacemaking efforts such as apologies, offers of compensation and owning up to one's responsibility increase forgiveness—and reduce anger—by making the aggressor seem more valuable as a relationship ...

New research suggests soluble corn fibre may boost calcium absorption

2014-07-14

Hoffman Estates, IL – Around the globe, fibre and calcium intakes are below the levels recommended by experts1,2,3 contributing to potential long-term public health implications1,3,4. New research, published this month in the British Journal of Nutrition, shows soluble corn fibre (SCF) may not simply boost fibre intake when added to foods, but can also increase the amount of beneficial bacteria present in the gut, while enhancing calcium absorption in adolescents5. SCF is a prebiotic fibre that is well tolerated, and is easily incorporated into foods or beverages to boost ...

LAST 30 PRESS RELEASES:

Ultrasound-directed microbubbles could boost immune response against tumours, new Concordia research suggests

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

DARPA-ABC program supports Wyss Institute-led collaboration toward deeper understanding of anesthesia and safe drugs enabling anesthesia without the need for extensive monitoring

[Press-News.org] Changes in generic pill color and shape disrupt use
Researchers find that changes in pill appearance associated with non-adherence to essential cardiovascular drugs